Clinical characterisation of exacerbations of severe eosinophilic asthma occurring on mepolizumab and placebo by Howell, I, Bratton, DJ, Hynes, G, Yancey, SW, Heaney, LG, Pavord, ID, Shrimanker, R

Remotely monitored therapy and nitric oxide suppression identifies nonadherence in severe asthma by Heaney, LG, Busby, J, Bradding, P, Chaudhuri, R, Mansur, AH, Niven, R, Pavord, I, Lindsay, JT, Costello, RW

FeNO non-suppression identifies corticosteroid-resistant type-2 signaling in severe asthma by Couillard, S, Shrimanker, R, Chaudhuri, R, Mansur, AH, McGarvey, LP, Heaney, LG, Fowler, SJ, Bradding, P, Pavord, ID, Hinks, TSC

Airway proteomics reveals broad residual anti-inflammatory effects of prednisolone in mepolizumab-treated asthma by Howell, I, Yang, F, Brown, V, Cane, J, Marchi, E, Azim, A, Busby, J, McDowell, PJ, Diver, SE, Borg, C, Heaney, LG, Pavord, ID, Brightling, CE, Chaudhuri, R, Hinks, TSC

A randomised pragmatic trial of corticosteroid optimization in severe asthma using a composite biomarker algorithm to adjust corticosteroid dose versus standard care: study protoco... by Hanratty, CE, Matthews, JG, Arron, JR, Choy, DF, Pavord, ID, Bradding, P, Brightling, CE, Chaudhuri, R, Cowan, DC, Djukanovic, R, Gallagher, N, Fowler, SJ, Hardman, TC, Harrison, T, Holweg, CT, Howarth, PH, Lordan, J, Mansur, AH, Menzies-Gow, A, Mosesova, S, Niven, RM, Robinson, DS, Shaw, DE, Walker, S, Woodcock, A, Heaney, LG, RASP-UK Consortium

Characteristics and risk factors for post-COVID-19 breathlessness after hospitalisation for COVID-19 by Daines, L, Zheng, B, Elneima, O, Harrison, E, Lone, NI, Hurst, JR, Brown, JS, Sapey, E, Chalmers, JD, Quint, JK, Pfeffer, P, Siddiqui, S, Walker, S, Poinasamy, K, McAuley, H, Sereno, M, Shikotra, A, Singapuri, A, Docherty, AB, Marks, M, Toshner, M, Howard, LS, Horsley, A, Jenkins, G, Porter, JC, Ho, L-P, Raman, B, Wain, LV, Brightling, CE, Evans, RA, Heaney, LG, De Soyza, A, Sheikh, A

Determinants of recovery from post-COVID-19 dyspnoea: analysis of UK prospective cohorts of hospitalised COVID-19 patients and community-based controls by Zheng, B, Vivaldi, G, Daines, L, Leavy, OC, Richardson, M, Elneima, O, McAuley, HJC, Shikotra, A, Singapuri, A, Sereno, M, Saunders, RM, Harris, VC, Houchen-Wolloff, L, Greening, NJ, Pfeffer, PE, Hurst, JR, Brown, JS, Shankar-Hari, M, Echevarria, C, De Soyza, A, Harrison, EM, Docherty, AB, Lone, N, Quint, JK, Chalmers, JD, Ho, L-P, Horsley, A, Marks, M, Poinasamy, K, Raman, B, Heaney, LG, Wain, LV, Evans, RA, Brightling, CE, Martineau, A, Sheikh, A

Multiorgan MRI findings after hospitalisation with COVID-19 in the UK (C-MORE): a prospective, multicentre, observational cohort study by Baillie, JK, Lone, NI, Jones, S, Shaw, A, Hairsine, B, Kurasz, C, Henson, H, Armstrong, L, Shenton, L, Dobson, H, Dell, A, Lucey, A, Price, A, Storrie, A, Pennington, C, Price, C, Mallison, G, Willis, G, Nassa, H, Haworth, J, Hoare, M, Hawkings, N, Fairbairn, S, Young, S, Lewis, V, Poinasamy, K, Walker, S, Jarrold, I, Sanderson, A, David, C, Chong-James, K, Zongo, O, Pfeffer, P, James, WY, Martineau, A, Manisty, C, King, B, Armour, C, McAulay, D, Major, E, McGinness, J, Heaney, LG, McGarvey, L, Magee, N, Stone, R, Drain, S, Craig, T, Brown, V, Bolger, A, Haggar, A, Sigfrid, L

Cohort profile: post-hospitalisation COVID-19 (PHOSP-COVID) study by Elneima, O, McAuley, HJC, Leavy, OC, Chalmers, JD, Horsley, A, Ho, L-P, Marks, M, Poinasamy, K, Raman, B, Shikotra, A, Singapuri, A, Sereno, M, Harris, VC, Houchen-Wolloff, L, Saunders, RM, Greening, NJ, Richardson, M, Quint, JK, Briggs, A, Docherty, AB, Kerr, S, Harrison, EM, Lone, NI, Thorpe, M, Heaney, LG, Lewis, KE, Aul, R, Beirne, P, Bolton, CE, Brown, JS, Choudhury, G, Bakerly, ND, Easom, N, Echevarria, C, Fuld, J, Hart, N, Hurst, JR, Jones, MG, Parekh, D, Pfeffer, P, Rahman, NM, Rowland-Jones, SL, Thompson, AR, Jolley, C, Shah, AM, Wootton, DG, Chalder, T, Davies, MJ, De Soyza, A, Geddes, JR, Greenhalf, W, Heller, S, Howard, LS, Jacob, J, Neubauer, S

Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study by Evans, RA, Leavy, OC, Richardson, M, Elneima, O, McCauley, HJC, Shikotra, A, Singapuri, A, Sereno, M, Saunders, RM, Harris, VC, Houchen-Wolloff, L, Aul, R, Beirne, P, Bolton, CE, Brown, JS, Choudhury, G, Diar-Bakerly, N, Easom, N, Echevarria, C, Fuld, J, Hart, N, Hurst, J, Jones, MG, Parekh, D, Pfeffer, P, Rahman, NM, Rowland-Jones, SL, Shah, AM, Wootton, DG, Chalder, T, Davies, MJ, De Soyza, A, Geddes, JR, Greenhalf, W, Greening, NJ, Heaney, LG, Heller, S, Howard, LS, Jacob, J, Jenkins, RG, Lord, JM, Man, WD-C, McCann, GP, Neubauer, S, Openshaw, PJM, Porter, JC, Rowland, MJ, Scott, JT, Semple, MG, Singh, SJ, Raman, B

Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study by Evans, RA, McAuley, H, Harrison, EM, Shikotra, A, Singapuri, A, Sereno, M, Elneima, O, Docherty, AB, Lone, NI, Leavy, OC, Daines, L, Baillie, JK, Brown, JS, Chalder, T, De Soyza, A, Diar Bakerly, N, Easom, N, Geddes, JR, Greening, NJ, Hart, N, Heaney, LG, Heller, S, Howard, L, Hurst, JR, Jacob, J, Jenkins, RG, Jolley, C, Kerr, S, Kon, OM, Lewis, K, Lord, JM, McCann, GP, Neubauer, S, Openshaw, PJM, Parekh, D, Pfeffer, P, Rowland, M, Rahman, NM, Ho, L-P, Raman, B, Richardson, M, Semple, MG, Shah, AM, Singh, SJ, Sheikh, A, Thomas, D, Toshner, M, Chalmers, JD, Horsley, A, Marks, M, Poinasamy, K, Wain, LV, Brightling, CE